Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Ellis

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 3, 2020
A Comparison of Radiation Techniques in Patients Treated With Concurrent Chemoradiation for Stage III Non-Small Cell Lung CancerJonathan Peng, Greg Pond, Elysia Donovan, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|April 3, 2001
Attitudes to randomized clinical trials amongst out-patients attending a medical oncology clinicPeter M. Ellis, Sharon M. Dowsett, Phyllis N. Butow, et al.
The Journal of Clinical Psychiatry|May 3, 2008
Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 casesSusanna E Palmer, Rachael M McLean, Peter M Ellis, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 27, 2013
Challenges to implementation of an epidermal growth factor receptor testing strategy for non-small-cell lung cancer in a publicly funded health care systemPeter M Ellis, Sunil Verma, Sandeep Sehdev, et al.
Tumori|March 10, 2009
Extraskeletal Ewing's sarcoma/primitive neuroectodermal tumor of the posterior mediastinum with t(11;22)(q24;q12)Marosh Manduch, David F Dexter, Peter M Ellis, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 27, 2010
First-line systemic chemotherapy in the treatment of advanced non-small cell lung cancer: a systematic reviewJohn Goffin, Christina Lacchetti, Peter M Ellis, et al.
Cancer|September 19, 2002
Factors that influence the recruitment of patients to Phase III studies in oncology: the perspective of the clinical research associateJames R Wright, Dauna Crooks, Peter M Ellis, et al.
Clinical Lung Cancer|February 7, 2017
Postoperative Adjuvant Systemic Therapy in Completely Resected Non-Small-Cell Lung Cancer: A Systematic ReviewPenelope Bradbury, Duvaraga Sivajohanathan, Adrien Chan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Phase I open-label study of continuous treatment with BIBF 1120, a triple angiokinase inhibitor, and pemetrexed in pretreated non-small cell lung cancer patientsPeter M Ellis, Rolf Kaiser, Yihua Zhao, et al.
Current Oncology (Toronto, Ont.)|June 25, 2025
Cost Disparities with Age in the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) in Ontario, CanadaYing Wang, Greg Pond, Amiram Jacob Gafni, et al.
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
International Journal of Radiation Oncology, Biology, Physics|February 3, 2020
A Comparison of Radiation Techniques in Patients Treated With Concurrent Chemoradiation for Stage III Non-Small Cell Lung CancerJonathan Peng, Greg Pond, Elysia Donovan, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|April 3, 2001
Attitudes to randomized clinical trials amongst out-patients attending a medical oncology clinicPeter M. Ellis, Sharon M. Dowsett, Phyllis N. Butow, et al.
The Journal of Clinical Psychiatry|May 3, 2008
Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 casesSusanna E Palmer, Rachael M McLean, Peter M Ellis, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 27, 2013
Challenges to implementation of an epidermal growth factor receptor testing strategy for non-small-cell lung cancer in a publicly funded health care systemPeter M Ellis, Sunil Verma, Sandeep Sehdev, et al.
Tumori|March 10, 2009
Extraskeletal Ewing's sarcoma/primitive neuroectodermal tumor of the posterior mediastinum with t(11;22)(q24;q12)Marosh Manduch, David F Dexter, Peter M Ellis, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 27, 2010
First-line systemic chemotherapy in the treatment of advanced non-small cell lung cancer: a systematic reviewJohn Goffin, Christina Lacchetti, Peter M Ellis, et al.
Cancer|September 19, 2002
Factors that influence the recruitment of patients to Phase III studies in oncology: the perspective of the clinical research associateJames R Wright, Dauna Crooks, Peter M Ellis, et al.
Clinical Lung Cancer|February 7, 2017
Postoperative Adjuvant Systemic Therapy in Completely Resected Non-Small-Cell Lung Cancer: A Systematic ReviewPenelope Bradbury, Duvaraga Sivajohanathan, Adrien Chan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Phase I open-label study of continuous treatment with BIBF 1120, a triple angiokinase inhibitor, and pemetrexed in pretreated non-small cell lung cancer patientsPeter M Ellis, Rolf Kaiser, Yihua Zhao, et al.
Current Oncology (Toronto, Ont.)|June 25, 2025
Cost Disparities with Age in the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) in Ontario, CanadaYing Wang, Greg Pond, Amiram Jacob Gafni, et al.
Pageof 10